All posts by imreal

Neighborhood Kids to Exhibit at Fort Lauderdale, Florida Franchise Show September 9th and 10th


As Neighborhood Kids, the faith-based preschool concept that provides exceptional early education and foundational family values, looks to expand, it will be exhibiting at its first franchise show in Fort Lauderdale, Florida, on September 9th and 10th, 2022 at booth 313.

After serving Florida families for over four decades, powering through the COVID-19 pandemic and undergoing a brand refresh, the brand moved to franchising to further expand its reach.

“We’d like to have Neighborhood Kids franchise owners situated strategically in communities in South Florida and Central Florida,” explained Frank Toral, CEO of Neighborhood Kids. “We are seeking franchise owners in communities that can support large preschools throughout Florida and then ultimately, if that goes well, to begin opening up schools across the south and beyond.”

The demand for private Christian schools is high as ever, and many families are left on waiting lists as they work to enroll their children in programs that align with their personal values. Toral explained that the same rings true for all Neighborhood Kids locations.

Since January 2021, all Neighborhood Kids locations have remained at capacity with additional students on waiting lists.

“Neighborhood Kids is committed to positively impacting neighborhoods across Florida by providing exceptional early education together with foundational family values,” Toral said.

For Toral, this looks like bringing safe, fun faith-based learning to the early childhood education scene in Florida and beyond. As the brand begins its expansion, growth within the state will allow new franchisees to leverage the existing love for the brand while closely connecting to the founders and support of others within the Neighborhood Kids network.

“We give [franchisees] an opportunity to earn a good income, but to make a huge difference — a generational impact — in their communities and the lives of hundreds of kids. So it’s a sense of purpose. You know, we’re looking for purpose-driven leaders,” Toral explained.

ABOUT NEIGHBORHOOD KIDS:

Neighborhood Kids got its start as a preschool established in Wellington, Florida, in 1978. Now a private, faith-based early childhood education organization, Neighborhood Kids provides generational impact through safe, fun, supportive, and God-honoring early education environments. For more information, visit http://www.neighborhoodkids.com.

Share article on social media or email:

Pure Smiles Dentistry Featured as a 2022 Top Patient Rated Marietta Dentist by Find Local Doctors


News Image

“It is an honor to receive this award once again. Providing patients with the very best in dentistry is always our goal,” says Dr. Sanil Patel.

Pure Smiles Dentistry is a modern, state-of-the-art clinic led by Dr. Sanil Patel, and it is located at 2655 Dallas Hwy #510 in Marietta, GA. Pure Smiles Dentistry provides quality care for patients of all ages in a comfortable, relaxing environment. Find Local Doctors has recently recognized Pure Smiles Dentistry as a result of the five-star ratings and reviews the clinic has earned from satisfied patients. From young toddlers to aging grandparents, their expansive menu of dental services can address all types of preventative and restorative dental concerns with the highest level of expertise. Dr. Sanil Patel is a talented dentist who makes it easy for the entire family to access comprehensive care in one, convenient location. The dental practice delivers advanced procedures within pediatric, cosmetic, restorative and emergency dentistry, even offering the latest orthodontic solutions.

The skilled dental professionals at Pure Smiles Dentistry address all types of preventive needs, routine dental care and advanced procedures, using the latest in cutting-edge technology. The clinic also leaves room in their schedule to handle dental emergencies and can often see patients the same day they call for urgent needs. Pure Smiles Dentistry makes the dental experience as relaxing and enjoyable as possible. The dentists and professional dental team at this clinic take the time to get to know their patients and truly value each relationship, which is reflected in the practice’s excellent reviews. Holding a reputation for offering superior, yet affordable, dental care for the entire family, Pure Smiles Dentistry accepts most dental insurance. The clinic also offers the Pure Smiles Club Discount Plan, which is the perfect solution for individuals and families without PPO dental insurance.

“It is an honor to receive this award once again. Providing patients with the very best in dentistry is always our goal,” says Dr. Sanil Patel.

More about Pure Smiles Dentistry:

At Pure Smiles Dentistry, Dr. Sanil Patel and his staff go above and beyond to make each patient feel welcome. The clinic is designed to help patients feel relaxed with comfortable treatment rooms that are equipped with advanced dental tools and technology to maximize efficiency. This practice provides comprehensive dentistry, including general, restorative and cosmetic dental care for the entire family. For more information about Pure Smiles Dentistry, please visit http://www.puresmilesmarietta.com or call (770) 422-8776.

Share article on social media or email:

HAS Healthcare Advanced Synthesis (HAS, Formerly Helsinn Advanced Synthesis SA) Has Improved its ECOVADIS Sustainability Rating From Silver to Gold Status in One Year


Biasca, Switzerland, September 1st, 2022 – HAS Healthcare Advanced Synthesis SA (“HAS”), a full-service contract development and manufacturing organization (CDMO) delivering high-quality, exclusive, personalized solutions to its healthcare clients, today announces that EcoVadis, the world’s largest and most trusted provider of business sustainability ratings, creating a global network of more than 90,000+ rated companies, has awarded HAS a gold rating for 2022. The new gold rating places HAS in the top 6% of all the companies assessed worldwide, and in the top 3% in the category ‘Manufacture of basic pharmaceutical products and pharmaceutical preparations’ by EcoVadis.

EcoVadis rates companies in the four main topic areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.

Waldo Mossi, CEO of HAS Healthcare Advanced Synthesis, commented: “We are delighted that our intensive efforts to become more sustainable over the years have been recognized by a global sustainability leader. Our gold rating is confirmation that sustainability is fully embedded in our business model. However, this is just one step further in our sustainability journey. We want to become one of the key leaders in our industry when it comes to sustainability.” In 2021, HAS became Carbon Neutral, after a 10-year long effort to decarbonize its value chain.

About HAS Healthcare Advanced Synthesis (formerly Helsinn Advanced Synthesis SA)

HAS Healthcare Advanced Synthesis is a full-service CDMO committed to providing a reliable, first-class and tailor-made offering. The company develops and manufactures Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs) and anticancer compounds for its clients from clinical to commercial supply, on an exclusive basis.

The production plant is located in Biasca, Switzerland and was established in 1984. The site is routinely inspected by the FDA, SwissMedic, and other global regulatory agencies.

Our wide range of reactors enable us to deliver a flexible batch size from grams to tens of tons, depending on your product needs. The HPAPI production suites are able to meet an OEL of 1 ug/m³ producing grams to hundreds of kgs per batch. The Anticancer facility has dedicated production suites with modern glovebox technology able to meet an OEL of 50 ng/m³ producing kgs up to 50 kg per batch.

Please visit our new website: https://www.hashealthcare.com

Share article on social media or email:

Dallas Entrepreneur Justin Magnuson Launches Justice Reform Foundation to Support Victims of the Criminal Justice System and Advocate for Change


News Image

Only other formerly incarcerated people can understand what it feels like to have all of your personal freedoms stripped away. I can no longer be passive, I must use my voice and my resources to help.

Local entrepreneur and Dallasite Justin Magnuson today announced the launch of the Justice Reform Foundation (JRF), a nonprofit organization dedicated to helping those impacted by America’s broken criminal justice system.

Magnuson experienced the fundamental dysfunctions in the U.S. criminal justice system firsthand when he found himself wrongfully accused and unlawfully incarcerated. Magnuson ultimately spent 20 months in a county jail under false pretenses during the height of the Coronavirus pandemic.

Magnuson is a self-made entrepreneur who worked his way through undergrad at University of North Texas and grad school at Southern Methodist University. As he was pursuing his Executive MBA from UCLA and commuting between Dallas and Los Angeles, he decided to expand his business ventures into the legal cannabis industry. He partnered with producers in California already legally growing cannabis and obtained all necessary permits for the business but, unbeknownst to him, the people he’d partnered with had violated federal law by selling products across state lines.

The prosecution had no evidence to produce a guilty verdict and still, due to the abuse of bail systems, he was detained and had his life upended. However, despite the difficulty he faced, Magnuson recognizes it was still a privilege he was able to walk away at all.

The experience compelled Magnuson to do his part to help fix a broken system by launching the Justice Reform Foundation, a non-profit advocating for structural change in the criminal justice system that is destroying lives and hurting families across the nation. Magnuson wants to ensure that people with fewer resources than him have the opportunity to get their lives back on track.

“I’m honored to have the ability to use my platform to aid those most directly impacted by the criminal justice system,” said Justin Magnuson, founder, and president of the Justice Reform Foundation. “Our system has long discriminated against the very citizens it is meant to protect. The Justice Reform Foundation is going to fight against the disparities that start with a person’s first contact with the system and continue through court hearings, conviction, incarceration, release, and thereafter.”

Magnuson continued, “in the past I gave my time and money to worthy organizations without taking an active role, but now I feel compelled to do more. Only other formerly incarcerated people can understand what it feels like to have all of your personal freedoms stripped away. I can no longer be passive, I must use my voice and my resources to help.”

Magnuson wants to bring awareness to the same unjust practices he was victim to, so the JRF will educate the public on topics like unlawful detainment, the need for bail reform, the importance of decriminalizing marijuana, prosecutorial misconduct, the abuse in the use of confidential informants, and the disparate treatment among classes of citizens.

The Justice Reform Foundation recognizes the importance of listening to and working with individuals already well-versed in criminal justice activism. In the coming weeks and months, the Foundation will focus on expanding our board of directors, vetting volunteers to support our reintegration program, and seeking partnerships with other organizations focused on criminal justice reform.

To learn more about the Justice Reform Foundation and Justin Magnuson’s story, visit https://justicereformfoundation.org or visit JRF on Facebook, Twitter, and LinkedIn.

About the Justice Reform Foundation

The Justice Reform Foundation (JRF) is a nonprofit organization dedicated to helping those impacted by the broken U.S. criminal justice system. The JRF focuses on educating and affecting change on topics like unlawful detainment, the need for bail reform, the importance of decriminalizing marijuana, prosecutorial misconduct, the abuse in the use of confidential informants, and the disparate treatment among classes of citizens.

About Justin Magnuson

Justin Magnuson is a Dallas-based entrepreneur who put himself through college and business school by working in sales before starting a neurodiagnostic testing company. He earned the prestigious recognition of making Inc. 5000’s list for five years in a row before ultimately selling the company. Magnuson then started a second successful business in the medical field which is continuing to flourish. After investing in a legal cannabis business, Magnuson found himself detained in county jail for 20 months despite his innocence, and harming the positive reputation he’d earned. Since his recent release, Magnuson has been working toward rebuilding his life, including starting the Justice Reform Foundation to help those impacted by a broken criminal justice system.

Share article on social media or email:



Top ACL Orthopedic Surgeon, Dr. Jonathan Glashow, Featured on News 12 Brooklyn Broadcast


News Image

“This treatment is still considered new, and not everyone that tears their ACL is a qualifying candidate. The fast recovery my patient Adam Marcu experienced is very exciting,” said Dr. Jonathan L. Glashow.

Dr. Jonathan Glashow is known as one of the best orthopedic surgeons specializing in sports injuries, cutting-edge joint treatments and complex fractures, with decades of experience working with professional sports teams as well as patients from all over the globe. The recent news segment that aired on News 12 Brooklyn on Aug 31, 2022, featured Dr. Glashow and his patient, soccer player and coach Adam Marcu. The story focused on Dr. Glashow’s surgical procedure and rehab plan which cut Mr. Marcu’s ACL tear recovery time in half. The ACL is a key ligament in the center of the knee that provides stability in sports where pivoting is common. Dr. Glashow had previously treated one of Mr. Marcu’s injuries in college and approved him as a candidate for a new procedure, which allowed the surgeon to repair the native ligament, rather than taking a piece of foreign tissue.

Dr. Glashow’s BEAR (Bridge Enhanced ACL Restoration) procedure is a less-invasive medical advancement, enabling the body to heal its own torn ACL. Unlike reconstruction, Dr. Glashow was able to utilize the BEAR® Implant, which does not require a second surgical wound site to remove a healthy tendon from another part of the leg or use a donor’s tendon. The implant acts as a bridge between the two ends of the torn ACL. The surgeon injects a small amount of the patient’s own blood into the implant, inserting it between the torn ends of the ACL in a minimally invasive procedure, and the combination enables the body to heal the torn ends of the ACL back together and maintain its original attachments to the femur and tibia. As the ACL heals, the implant is absorbed by the body, within approximately eight weeks. While the rehab started slow, Adam Marcu shared that after only one month, he began to see rapid advances in his rehab progress, and in just five months was able to return to the field.

“This treatment is still considered new, and not everyone that tears their ACL is a qualifying candidate. The fast recovery my patient Adam Marcu experienced is very exciting,” said Dr. Jonathan L. Glashow.

Link to story: https://brooklyn.news12.com/doctor-introduces-rehab-that-cuts-acl-tear-recovery-time-in-half

More about Dr. Jonathan Glashow:

Dr. Jonathan Glashow is a board certified orthopedic surgeon and co-chief of sports medicine orthopedics at New York’s Mount Sinai Medical Center and has been in private practice for over 29 years. He is also the team physician for the NJ Devils and Philadelphia 76ers professional sports teams. To find out more information about Dr. Jonathan Glashow or to schedule an appointment at his orthopedic practice located in NYC at 737 Park Avenue, Suite #1A, please call (212)794-5096 or visit http://www.orthopedicsurgeonnyc.com.

Share article on social media or email:

WizeCare Announces Know-how and Research Agreement with Mayo Clinic


WizeCare and Mayo Clinic Sign Know-how and Research Agreement

“We are excited to collaborate with Mayo Clinic to bring forth a new approach to home-based cardiac rehabilitation that leverages our platform capabilities and Mayo Clinic’s know-how to deliver better care,” said Roy Shteren, CEO of WizeCare.

WizeCare, a health technology company providing enterprise-wide virtual physical rehabilitation and remote monitoring solutions for healthcare providers, announced today it has entered into a know-how and research agreement with Mayo Clinic to collaborate on the development of a home-based cardiac rehabilitation program.

The new program aims to set a new standard of care by harnessing Mayo Clinic’s know-how with WizeCare’s groundbreaking AI-driven technology to advance remote cardiac rehabilitation monitoring capabilities for better adherence and improved patient outcomes. WizeCare’s cloud-based solution consists of an interactive patient application that delivers virtual reality video sessions while using MoveAI™ technology to detect movement and provide real-time feedback for an intuitive, personalized and engaging rehabilitation experience.

Today, the current standard of care in cardiac rehabilitation monitors blood pressure and heart rate during a face-to-face visit, with only age, gender and a few other factors remotely monitored.

The new program will leverage WizeCare’s AI-driven technology to automate and guide patients in their daily exercise training, as well as monitor for the first time multiple new parameters remotely. This will include heart rate, cardiopulmonary fitness level, oxygen consumption, walking performance and other known relevant factors. Patients will also receive educational videos, feedback, and reinforcement to help improve lifestyle behaviors.

With improved remote tools and greater patient insight, the program will support practitioners to identify life-threatening cardiac events earlier and better tailor rehabilitation exercises to patient’s needs for improved safety, adherence, and outcomes.

Future program developments will also look to integrate blood pressure, sleep, and physical activity monitoring with automated alerts in response to abnormal events to further support clinical decision making and optimization of treatment plans.

The know-how is being provided by Dr. Amir Lerman, Associate Chair of the Department of Cardiovascular Medicine and the Director of the Cardiovascular Research Center at Mayo Clinic and Dr. Francisco Lopez-Jimenez, a Professor of Medicine at Mayo College of Medicine and the chair of the Division of Preventive Cardiology at Mayo Clinic.

“We are excited to collaborate with Mayo Clinic to bring forth a new approach to home-based cardiac rehabilitation that leverages our platform capabilities and Mayo Clinic’s know-how to deliver better care,” said Roy Shteren, CEO of WizeCare.

Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.

About WizeCare:

WizeCare is a health technology company providing enterprise-wide virtual physical rehabilitation and remote monitoring solutions to support healthcare providers deliver value-based care. Its cloud-based solution is an interactive, engaging patient application that delivers video sessions while using MoveAI™ technology to detect movement and receive real-time feedback from clinicians. With no external sensors or hardware, the clinically proven platform is easy to use and supports a wide range of patients with orthopedic, neurological, and movement disorders. To date, over 1 million virtual care sessions have been delivered. Clinical trials show patients achieved better outcomes in less time with treatment adherence increasing 10 fold and recovery times reducing by 20%. To learn more, visit WizeCare.com.

Share article on social media or email:

Salimetrics Reveals New Circadian Phase Assessments for At-Home Sleep and Circadian Rhythm Testing


Home Sleep Test Kit

Dim light offset testing is probably more useful than onset when deciding on the optimal time to initiate bright light therapy

Salimetrics now offers three different Circadian Phase Test kits, all at the same cost, and can be selected based on an initial sleep evaluation with a sleep healthcare provider. Patients now have the flexibility to test dim light melatonin onset or offset, and a partial or full 24-hour sleep-wake cycle, providing a unique window into each individual’s specific circadian rhythm.

Adding new profiles came at the request of a prominent sleep physician from the Beth Israel Deaconess Medical Center, Boston (Harvard Medical School). “It may have all started with the DLMO test, but Dr. Robert Thomas made a compelling request for additional circadian profiles,” says Steve Granger, Ph.D., Salimetrics Chief Scientific Officer. “Dim light offset testing is probably more useful than onset when deciding on the optimal time to initiate bright light therapy,” says Dr. Thomas. “This is especially important when a late start of sleep is paired with a relatively early forced awakening for social reasons – it is then hard to estimate the true end of the biological night. Mapping the biological night (measuring over 18 to 24 hours) provides unique insights for hypersomnia (how long is the biological night?), non-24 sleep-wake phase disorder (is the biological night moving?), and irregular sleep-wake phase disorder (where is the biological night?).” As an expert in the field of sleep medicine, Salimetrics worked under the guidance of Dr. Thomas to modify their current DLMO test protocol and enable alternative sampling schedules to reveal these distinct phases of the circadian rhythm. Both the DLMOff and 24-hour Circadian Phase Map tests are now available for individuals and clinicians at https://biologyofsleep.com.

The Dim Light Melatonin Offset test, or DLMOff, starts immediately after an individual’s final awakening. In non-shifted individuals, Melatonin levels drop quickly after waking in preparation for the day’s normal routine. However, shifted individuals may have trouble staying asleep and suffer from early morning awakening or may experience extended periods of lethargy or somnolence after awakening, thereby reducing, or extending their biological night. These symptoms can also be attributed to both age-related changes, as well as poor sleep hygiene, which can also shift circadian alignment.

The 24-hour Circadian Phase Map test, or Biological Night Mapping, relies on collecting samples over a specific time period, which can be as short as 15 hours or as long as 24 hours. Sampling during a longer period can provide useful physiologic information to help assess an individual’s circadian timing and sleep function for complex issues where an individual may be suffering from irregular sleep disruptions or non-24-hour sleep-wake rhythm disorders. A circadian rhythm disorder is generally present when the relationship between the timing and duration of sleep and the circadian rhythm is significantly altered. Thus, the “biological night” can be too long, too short, unstable (varying with time), or misaligned – all of which can cause clinical symptoms and are also targets for treatment.

“The key objective for Circadian Phase Testing is to establish a baseline and determine whether biology or behavior is driving an individual’s circadian rhythm disruption,” says Dr. Granger. “While we have enabled more flexibility in the sampling protocols and testing, we will continue to listen to the voice of the sleep medicine community and the patients themselves to incorporate feedback where possible, thereby increasing the ease and effectiveness of our sleep tests.”

Sleep health providers can Register Online to receive a unique provider referral ID number. Once issued, providers can immediately refer patients to https://biologyofsleep.com to order their home sleep assessment kit. Salimetrics’ trained representatives facilitate everything in-between until test results are sent to the Doctor and patient through a HIPAA Compliant results portal.

For more information, or to register as a provider, visit Salimetrics’ Biology of Sleep Website.

About Salimetrics

Salimetrics’ assay kits and CLIA-certified testing services are used to measure salivary analytes related to stress, behavior and development, inflammation, sleep, reproduction, health, and immune function. Founded in 1998 by Douglas A. Granger, Ph.D., Salimetrics, LLC supports CROs, pharmaceuticals, academic researchers, and the immunodiagnostic industry worldwide with innovative immunoassay products, non-invasive saliva collection methods, and laboratory testing services.

Share article on social media or email:

Healthcare Leaders Group Selects MeldRx™ to Meet Cures Act Requirements


Healthcare Leaders Group is excited to partner with Darena Solutions to implement MeldRx because they support our goal of leveraging technology so practices can put their patients ahead of their business. – AYAN CHATTERJEE, HLG’s VP of PARTNERSHIPS

MeldRx™ is a comprehensive Ecosystem developed by Darena Solutions for EHRs, providers, and their patients. This Ecosystem includes the ONC Certified FHIR® API that allows EHRs to meet all the certification mandates and future-proofs them from evolving regulatory and interoperability requirements. The ecosystem relieves practitioners from the burdens of integration, interpreting regulations, finding solutions, and staff disruption.

“Healthcare Leaders Group is excited to partner with Darena Solutions to implement MeldRx because they support our goal of leveraging technology so practices can put their patients ahead of their business. We are always looking for Occam’s razor to cut through complexity.” Said Ayan Chatterjee, HLG’s VP of Partnerships.

Wayne Singer, VP of Regulatory Services, says, “We are proud to be working with the HLG team and helping them meet the “Certify and Provide” mandates for the (g)(10) FHIR® API, as well as sharing the complete Electronic Health Information (EHI). The HLG team aligns with our goal of going above and beyond meeting the Cures Act requirements to achieve true healthcare interoperability.”

ABOUT HEALTH LEADERS GROUP

Health Leaders Group (HLG) is a Charlotte, N.C.-based family of companies serving ophthalmologists and optometrists with the goal of improving the efficiency, profitability, and competitiveness of those eye care practices. HLG provides ophthalmology practice management software and electronic health records systems for 40 percent of the market, bringing together trusted names such as myCare iMedicWare, myCare Integrity EMR, MDoffice, ManagementPlus, Medflow, IO Practiceware, KeyMedical, My Vision Express, and EyeDoc.

ABOUT MELDRX

MeldRx™ is a technology platform designed by Darena Solutions to solve the unique challenges of Healthcare Data Management by leveraging open standards, established data security best practices, and collaboration between Patients, Providers, Researchers, and Health IT Developers. BlueButtonPRO, the nation’s first ONC-certified FHIR API solution, is now a part of the MeldRx Ecosystem.

ABOUT DARENA SOLUTIONS

Darena Solutions delivers an Ecosystem of FHIR® enabled interoperability, regulatory compliance, and analytics solutions to EHRs, providers, and payers. By creating channels for data sharing between providers, payers, and patients, Darena enables healthcare organizations to achieve compliance and derive insights for prospective decision-making resulting in better patient outcomes. You can connect with us on LinkedIn and Twitter.

Share article on social media or email:



The Top 25 Healthcare Technology Leaders of Tampa for 2022


The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Tampa for 2022. The Tampa metro area is rapidly growing and is second only to Miami in the state of Florida in terms of population. It is currently home to 20 corporate headquarters, five of which were named to the Fortune 500 list for 2021, and nearly 500 foreign-owned companies. It is also home to some of the most groundbreaking healthcare technology companies in the world, and the executives on this year’s list have led their companies in impressive fashion while helping patients at the same time.

Some of the elite leaders on this year’s list include Stan Nelson of Thermo Fisher Scientific, who is responsible for driving growth and strategy for the laboratory products division representing about $1 billion dollars of annual revenue. Meanwhile, Dr. Michael Eaddy of AbbVie has more than 20 years of experience leveraging real-world datasets to demonstrate the clinical and economic impact of diseases while also highlighting the value of pharmaceutical products and devices. And Gene McCabe of Evernorth measures success not in his own promotion, but instead in the benefits and results accrued to clients, colleagues, and companies where he directs his efforts.

From specialty pharmacies and precision immunology companies, to multinational medical device manufacturers, the companies represented come from a range of specialties. What they have in common is their dedication and unceasing work toward developing the most advanced, readily-usable solutions in healthcare. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Tampa for 2022.

Sean Mitchiner (Medtronic), Kim Gutierrez (AstraZeneca), Kealoha Deutsch (HCA Healthcare), Stan Nelson (Thermo Fisher Scientific), Michael Eaddy (AbbVie), Tonya Slaton (Amgen), Michael Scholler (Astellas Pharma US), Kim Armbrust (Alexion Pharmaceuticals, Inc.), Shylendra Kumar (GSK), Gene McCabe (Evernorth), Ryan Harris (Agiliti), Brian Hutfless (Canon Medical Systems USA, Inc.), Kathleen O’Neill (Pacific Therapy Access), Nathan Folkert (Orchid Orthopedic Solutions), Jesse Ferguson (Corin Group), David Dlugo (Supernus Pharmaceuticals, Inc.), Christian Kath (Daniels Health), Steven Passik (Millennium Health), Siddharth Rao (AxoGen), Sai Kolluri (TigerConnect), John Maddox (Formulated Solutions), Hemali Joshi (CAN Community Health, Inc.), Paige Nardi (Scipher Medicine), Lynn Black (Orsini Specialty Pharmacy), Melissa Stefko (FlexPro Group).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

Demystifying Complex Operations, Upcoming Webinar Hosted by Xtalks


Dosing patients with these investigational products requires careful selection of both the clinical site, supportive therapists, efficacy raters and the patient themselves.

Building on the initial research projects of the 1950s, the resurgent interest in psychedelic agents has transitioned from academic or government-sponsored projects into industry-sponsored drug development.

The potential benefit of psychedelics in the treatment of persistent psychiatric illnesses like depression and behavioral disorders has long been overshadowed by the notoriety of this class of agents being scheduled. The resurgence in this field poses a new challenge: conducting high-science, high-quality clinical trials with previously researched molecules within today’s regulatory environment.

For sponsors, investigators and regulators, psychedelics pose new clinical trial considerations. Dosing patients with these investigational products requires careful selection of both the clinical site, supportive therapists, efficacy raters and the patient themselves. Trust and support are paramount in this unique research partnership.

Join panelists from Worldwide Clinical Trial’s psychedelic operational teams as they discuss the unique requirements of psychedelic clinical development, demystifying the complex operations.

Join experts from Worldwide Clinical Trials, Richard Bennett (webinar moderator), Senior Director, Therapeutic Strategy Lead, Neuroscience; Julia Forte, Senior Director, Project Management; Christine K. Moore, PhD, Vice President, Neuroscience, Scientific Solutions; and Rolana Avrumson, MS, Vice President of Clinical Projects, Clinical Assessment Technologies, for the live webinar on Tuesday, September 27, 2022, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Psychedelic Research: Demystifying Complex Operations.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: